MedPath

MINGGE LLC

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:2
Completed:0

Trial Phases

1 Phases

Not Applicable:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Not Applicable
1 (100.0%)

Radiomics-Based Visualization and Quantitative Validation of IDH1 Heterogeneity in Gliomas

Not Applicable
Active, not recruiting
Conditions
Glioma, Malignant
Computer-Assisted
First Posted Date
2023-08-01
Last Posted Date
2023-08-08
Lead Sponsor
Mingge LLC
Target Recruit Count
18
Registration Number
NCT05969691
Locations
🇨🇳

Huashan Hospital, Fudan University, Shanghai, Shanghai, China

MRI-based Computer Aided Diagnosis Software (V1) for Glioma

Conditions
Glioma
Primary Brain Tumor
First Posted Date
2023-02-22
Last Posted Date
2023-02-22
Lead Sponsor
Mingge LLC
Target Recruit Count
250
Registration Number
NCT05739500
Locations
🇨🇳

Zhen Fan, Shanghai, Shanghai, China

Intraoperative Rapid Diagnosis of Glioma Based on Fusion of Magnetic Resonance and Ultrasound Imaging

Active, not recruiting
Conditions
Glioma, Malignant
Computer-Assisted Surgery
First Posted Date
2022-12-19
Last Posted Date
2023-03-17
Lead Sponsor
Mingge LLC
Target Recruit Count
30
Registration Number
NCT05656053
Locations
🇨🇳

Fudan University, Shanghai, Shanghai, China

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.